Cd(S1-xSex) pigments (red to yellow) were synthesized by precipitate-hydrothermal method. The structure, morphology and hue of the powder were characterized by X-ray diffractometry (XRD), scanning electron microscopy ...Cd(S1-xSex) pigments (red to yellow) were synthesized by precipitate-hydrothermal method. The structure, morphology and hue of the powder were characterized by X-ray diffractometry (XRD), scanning electron microscopy (SEM), energy dispersive X-ray spectroscopy (EDAX) and CIE chromaticity. The optimum synthesis conditions were obtained and reaction mechanism was further analyzed as well. The results show that molar ratio of S to Se, pH value and hydrothermal reaction conditions have great effects on the hues of the pigments. Pigments with vivid hues are obtained under the conditions that pH value is about 13.0, hydrothermal reaction condition is at 140 ℃ for 4 h or at 160 ℃ for 6 h. The reaction mechanism is that Se2- of Cd(S1-xSex) substitutes S2- of CdS and then forms a continuous solid solution.展开更多
Recombinant interleukin-33(IL-33)inhibits tumor growth,but the detailed immunological mechanism is still unknown.IL-33-mediated tumor suppression did not occur in Batf3^(−/−)mice,indicating that conventional type 1 de...Recombinant interleukin-33(IL-33)inhibits tumor growth,but the detailed immunological mechanism is still unknown.IL-33-mediated tumor suppression did not occur in Batf3^(−/−)mice,indicating that conventional type 1 dendritic cells(cDC1s)play a key role in IL-33-mediated antitumor immunity.A population of CD103^(+)cDC1s,which were barely detectable in the spleens of normal mice,increased significantly in the spleens of IL-33-treated mice.The newly emerged splenic CD103^(+)cDC1s were distinct from conventional splenic cDC1s based on their spleen residency,robust effector T-cell priming ability,and surface expression of FCGR3.DCs and DC precursors did not express Suppressor of Tumorigenicity 2(ST2).However,recombinant IL-33 induced spleen-resident FCGR3^(+)CD103^(+)cDC1s,which were found to be differentiated from DC precursors by bystander ST2+immune cells.Through immune cell fractionation and depletion assays,we found that IL-33-primed ST2^(+)basophils play a crucial role in the development of FCGR3^(+)CD103^(+)cDC1s by secreting IL-33-driven extrinsic factors.Recombinant GM-CSF also induced the population of CD103^(+)cDC1s,but the population neither expressed FCGR3 nor induced any discernable antitumor immunity.The population of FCGR3^(+)CD103^(+)cDC1s was also generated in vitro culture of Flt3L-mediated bone marrow-derived DCs(FL-BMDCs)when IL-33 was added in a pre-DC stage of culture.FL-BMDCs generated in the presence of IL-33(FL-33-DCs)offered more potent tumor immunotherapy than control Flt3L-BMDCs(FL-DCs).Human monocyte-derived DCs were also more immunogenic when exposed to IL-33-induced factors.Our findings suggest that recombinant IL-33 or an IL-33-mediated DC vaccine could be an attractive protocol for better tumor immunotherapy.展开更多
基金Project(2005DFBA028) supported by the International Cooperation of Science and Technology of Ministry of ChinaProject(LA06030) supported by the Undergraduate Innovation Education of Central South University, China
文摘Cd(S1-xSex) pigments (red to yellow) were synthesized by precipitate-hydrothermal method. The structure, morphology and hue of the powder were characterized by X-ray diffractometry (XRD), scanning electron microscopy (SEM), energy dispersive X-ray spectroscopy (EDAX) and CIE chromaticity. The optimum synthesis conditions were obtained and reaction mechanism was further analyzed as well. The results show that molar ratio of S to Se, pH value and hydrothermal reaction conditions have great effects on the hues of the pigments. Pigments with vivid hues are obtained under the conditions that pH value is about 13.0, hydrothermal reaction condition is at 140 ℃ for 4 h or at 160 ℃ for 6 h. The reaction mechanism is that Se2- of Cd(S1-xSex) substitutes S2- of CdS and then forms a continuous solid solution.
基金the National Research Foundation of Korea(SRC-2017R1A5A1014560). This work was supported by grants from the National Research Foundation of Korea(SRC-2017R1A5A1014560)。
文摘Recombinant interleukin-33(IL-33)inhibits tumor growth,but the detailed immunological mechanism is still unknown.IL-33-mediated tumor suppression did not occur in Batf3^(−/−)mice,indicating that conventional type 1 dendritic cells(cDC1s)play a key role in IL-33-mediated antitumor immunity.A population of CD103^(+)cDC1s,which were barely detectable in the spleens of normal mice,increased significantly in the spleens of IL-33-treated mice.The newly emerged splenic CD103^(+)cDC1s were distinct from conventional splenic cDC1s based on their spleen residency,robust effector T-cell priming ability,and surface expression of FCGR3.DCs and DC precursors did not express Suppressor of Tumorigenicity 2(ST2).However,recombinant IL-33 induced spleen-resident FCGR3^(+)CD103^(+)cDC1s,which were found to be differentiated from DC precursors by bystander ST2+immune cells.Through immune cell fractionation and depletion assays,we found that IL-33-primed ST2^(+)basophils play a crucial role in the development of FCGR3^(+)CD103^(+)cDC1s by secreting IL-33-driven extrinsic factors.Recombinant GM-CSF also induced the population of CD103^(+)cDC1s,but the population neither expressed FCGR3 nor induced any discernable antitumor immunity.The population of FCGR3^(+)CD103^(+)cDC1s was also generated in vitro culture of Flt3L-mediated bone marrow-derived DCs(FL-BMDCs)when IL-33 was added in a pre-DC stage of culture.FL-BMDCs generated in the presence of IL-33(FL-33-DCs)offered more potent tumor immunotherapy than control Flt3L-BMDCs(FL-DCs).Human monocyte-derived DCs were also more immunogenic when exposed to IL-33-induced factors.Our findings suggest that recombinant IL-33 or an IL-33-mediated DC vaccine could be an attractive protocol for better tumor immunotherapy.
